Ann: Bisantrene Phase 2 AML data presented at ASH conference, page-31

Hi @Davisite,

I have 1 question to ask and also if I can make 1 statement.

As I haven't read the presentation just yet, but something caught my eye.

In the presentation it made mention of Troponin.



Question,
1 - Can you please clarify, exactly what they mean by 4 (Transient).
Is this a good thing or something bad.

Statement
2 - I am thinking that the Troponin levels where so low that Bis, prevented onset of a Heart Attack. (I might be wrong).
So my assumption is that Bis can be given to every body as a preventive measure, to combat an onset of Heart attack.
If I am correct in saying that Bis can be used at low dose daily, just like Aspirin is given to patients after a heart attack.
Then if this the case, then when will we see RC330 (Oral Form), been made.

Point 2 is my only assumption and I probably, barking up the wrong tree and totally wrong.

I would appreciate if can correct my statement and I fully understand if you can't answer my point 2.

Thanks In Advance.

IMHO.

Regards

Rossi70